Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Shared 2 days ago
45 views
Shared 6 days ago
51 views
Shared 1 week ago
128 views
Shared 2 weeks ago
130 views
Shared 1 month ago
168 views
Shared 2 months ago
138 views
Shared 2 months ago
76K views
Shared 2 months ago
459 views
Shared 3 months ago
583 views
Shared 4 months ago
722 views
Shared 4 months ago
648 views
Shared 4 months ago
144K views
Shared 5 months ago
948 views
Shared 5 months ago
388 views
Shared 5 months ago
209K views
Shared 6 months ago
338 views
Shared 8 months ago
473K views
Shared 8 months ago
229 views
Shared 8 months ago
102 views
Shared 9 months ago
886 views
Shared 9 months ago
2.1K views
Shared 10 months ago
439 views
Shared 11 months ago
628 views